Market research
3098.TSE cocokara fine Inc
TSE JPY Healthcare
Latest close
As of 04 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 243B
- P/E ratio
- 51.56
- Analyst target
- 9000
- Dividend yield
- 1.0%
- Beta
- 0.54
Profile
Instrument facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- ISIN
- JP3297330007
- Market cap
- 243B
- P/E ratio
- 51.56
- Analyst target
- 9000
- Dividend yield
- 1.0%
- Beta
- 0.54
About
About cocokara fine Inc
cocokara fine Inc., through its subsidiaries, engages in the drugstore and pharmacy operations in Japan. It also provides nursing and at-home care services; and operates assisted living facilities. In addition, the company is involved in the retail of health and beauty care products; promotion of employment of people with disabilities; sale and leasing of nursing care equipment and remodel homes; and logistics and online shopping businesses. It operates approximately 1,300 stores. cocokara fine Inc. was founded in 2008 and is headquartered in Yokohama, Japan.
Research context
cocokara fine Inc appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 3098.TSE discussion.
5 years, 6 months ago
cocokara fine Inc is currently in a long term uptrend where the price is trading 7.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
cocokara fine Inc's total revenue sank by 8.1% to $89B since the same quarter in the previous year.
Its net income has increased by 26.1% to $2B since the same quarter in the previous year.
Based on the above factors, cocokara fine Inc gets an overall score of 3/5.